Report cover image

Organoids Market Research Report Information By Product and Service (Product and Service), By Type of Organoids (Liver, Kidney, Pancreas, Intestine, Heart, and others), By Application (Drug Testing, Developmental Biology, Personalized Medicine, Regenerati

Publisher Market Research Future
Published Aug 10, 2024
Length 146 Pages
SKU # RESFT19195380

Description

Organoids Market Research Report Information By Product and Service (Product and Service), By Type of Organoids (Liver, Kidney, Pancreas, Intestine, Heart, and others), By Application (Drug Testing, Developmental Biology, Personalized Medicine, Regenerative Medicine, and Others), By End-Users (Academic and Research Institutes, Pharmaceutical and Biotechnology Company, Contract Research Organizations (CROs), and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Industry Forecast Till 2032


In 2023, the organoids market was estimated to be worth USD 1.39 billion. Over the forecast period (2024 - 2032), the sector is expected to increase at a compound annual growth rate (CAGR) of 23.55%, from USD 1.68 billion in 2024 to USD 9.16 billion by 2032. The market is expanding because to the growing use of toxicology and drug discovery research as well as the growing need for personalized medication.

One major factor driving the Organoids Market's expansion is the growing need for customized treatment. Precision medicine, another name for personalized medicine, focuses on customizing medical care to each patient's unique needs. With the goal of offering more specialized and successful treatments, this method takes into account variables including genetic composition, lifestyle, and environment. Organoids, microscopic three-dimensional tissue structures that approximate the intricacy and functionality of organs, have become an indispensable instrument in the advancement of customized medicine.

Understanding that people respond to therapies with significant variety is a fundamental component of customized medicine. Conventional methods for developing new drugs frequently depend on 2D cell cultures or animal models, which are inaccurate representations of human biology. Organoids provide a more physiologically appropriate platform for researching the causes of diseases and evaluating the effects of medications. Researchers can anticipate how individuals will react to various therapies and gain a better understanding of the distinctive features of diseases by utilizing patient-derived organoids.

Insights on Market Segments
The Organoids Market has been divided into product and service segments based on product and service.
The Organoids Market has been divided into Liver, Kidney, Pancreas, Intestine, Heart, and others segments based on the kind of organoids.
The market has been divided into categories such as drug testing, developmental biology, personalized medicine, regenerative medicine, and others based on application.
The market has been divided into End-Users, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutions, and Others.

Localized Perspectives
The Organoids Market has been divided into four regions: Asia-Pacific, Europe, North America, and the Rest of the World. North America held the greatest market share in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 22.88% to reach USD 3.42 billion by 2032.

Technological developments leading to the creation of 3D organoids and spheroids are responsible for the rise in the use of organoid-based research models in the biotechnology industry in the United States and Canada. Leading academic research centers and biotechnology firms in the United States have led the way in the development of organoid technology.

Following the Americas, Europe held the second-largest proportion of the organoids market. Europe's strong research infrastructure and significant investments in the biological sciences are important factors. Renowned research institutes and biotechnology businesses at the forefront of organoid research can be found in nations like the Netherlands, Germany, and the United Kingdom.

The organoids market is expanding significantly in the Asia Pacific area due to a number of important factors. Organoids are three-dimensional tiny organs made from tissue or stem cells that have enormous potential for use in drug discovery, regenerative medicine, and disease modelling.

Principal Players

Thermo Fisher Scientific Inc., Merck KGgA, Corning Incorporated, STEMCELL Technologies, Bio-Techne, Molecular Devices, LLC, and other prominent companies are involved in the organoids market.

Table of Contents

146 Pages
1 Executive Summary
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.3 Research Objective
2.4 Market Structure
3 Research Methodology
3.1 Overview
3.2 Data Flow
3.2.1 Data Mining Process
3.3 Purchased Database:
3.4 Secondary Sources:
3.4.1 Secondary Research Data Flow:
3.5 Primary Research:
3.5.1 Primary Research Data Flow:
3.5.2 Primary Research: Number Of Interviews Conducted
3.6 Approaches For Market Size Estimation:
3.6.1 Revenue Analysis Approach
3.7 Data Forecasting
3.7.1 Data Forecasting Type
3.8 Data Modeling
3.8.1 Microeconomic Factor Analysis:
3.8.2 Data Modeling:
3.9 Teams And Analyst Contribution
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Rising Demand For Personalized Medicine
4.2.2 Growing Applications In Drug Discovery And Toxicology Studies
4.3 Restraints
4.3.1 Regulatory Challenges Impacting Market Growth
4.3.2 High Cost Of Development And Maintenance
4.4 Opportunity
4.4.1 Technological Advancements Enhancing Organoid Production And Applications
4.5 Trend
4.5.1 Rising Investment In Regenerative Medicine
4.5.2 Expanding Use In Studying Developmental Biology
4.6 Challenges
4.6.1 Ethical Concerns Surrounding Organoid Sourcing And Experimentation
4.6.2 Integration Challenges With Existing Medical Practices And Technologies
4.7 Impact Analysis Of Covid-19
4.7.1 Impact On R & D
4.7.2 Impact On Supply Chain
4.7.3 Impact On Pricing
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 Raw Material Sourcing And Research & Development (R&D)
5.1.2 Organoid Production And Quality Control/Assurance
5.1.3 Distribution And Logistics
5.1.4 Application In Research, Drug Discovery, And Clinical Translation
5.2 Porter’s Five Forces Model
5.2.1 Threat Of New Entrants
5.2.2 Bargaining Power Of Suppliers
5.2.3 Threat Of Substitutes
5.2.4 Bargaining Power Of Buyers
5.2.5 Intensity Of Rivalry
6 Global Organoids Market, By Product & Service
6.1 Overview
7 Global Organoids Market, By Type Of Organoids
7.1 Overview
8 Global Organoids Market, By Application
8.1 Overview
9 Global Organoids Market, By End-users
9.1 Overview
10 Global Organoids Market, By Region
10.1 Global
10.2 North America
10.2.1 Us
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 Uk
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest Of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Australia
10.4.6 Rest Of Asia Pacific
10.5 Rest Of The World
10.5.1 Middle East & Africa
10.5.2 South America
11 Competitive Landscape
11.1 Competitive Overview
11.2 Major Players In The Global Organoids Market
11.3 Competitive Benchmarking
11.4 Key Developments & Growth Strategies
11.4.1 Product Launch/Development
11.4.2 Contract & Agreement
12 Company Profiles
12.1 Hub Organoids
12.1.1 Company Overview
12.1.2 Financial Overview
12.1.3 Products/Services Offered
12.1.4 Key Developments
12.1.5 Swot Analysis
12.1.6 Key Strategies
12.2 Neyroblastgx
12.2.1 Company Overview
12.2.2 Financial Overview
12.2.3 Products Offered
12.2.4 Key Developments
12.2.5 Swot Analysis
12.2.6 Key Strategies
12.3 Stemcell Technologies
12.3.1 Company Overview
12.3.2 Financial Overview
12.3.3 Products Offered
12.3.4 Key Developments
12.3.5 Swot Analysis
12.3.6 Key Strategies
12.4 Bio-techne
12.4.1 Company Overview
12.4.2 Financial Overview
12.4.3 Products Offered
12.4.4 Key Developments
12.4.5 Swot Analysis
12.4.6 Key Strategies
12.5 Thermo Fisher Scientific Inc
12.5.1 Company Overview
12.5.2 Financial Overview
12.5.3 Products Offered
12.5.4 Key Developments
12.5.5 Swot Analysis
12.5.6 Key Strategies
12.6 3dnamics Inc.
12.6.1 Company Overview
12.6.2 Financial Overview
12.6.3 Products Offered
12.6.4 Key Developments
12.6.5 Swot Analysis
12.6.6 Key Strategies
12.7 Molecular Devices, Llc
12.7.1 Company Overview
12.7.2 Financial Overview
12.7.3 Products/Services Offered
12.7.4 Key Developments
12.7.5 Swot Analysis
12.7.6 Key Strategies
12.8 Merck Kgga
12.8.1 Company Overview
12.8.2 Financial Overview
12.8.3 Products Offered
12.8.4 Key Developments
12.8.5 Swot Analysis
12.8.6 Key Strategies
12.9 Corning Incorporated
12.9.1 Company Overview
12.9.2 Financial Overview
12.9.3 Products Offered
12.9.4 Key Developments
12.9.5 Swot Analysis
12.9.6 Key Strategies
12.10 Cn Bio Innovations Ltd
12.10.1 Company Overview
12.10.2 Financial Overview
12.10.3 Products Offered
12.10.4 Key Developments
12.10.5 Swot Analysis
12.10.6 Key Strategies
13 Data Citations
List Of Tables
Table 1 Qfd Modeling For Market Share Assessment
Table 2 Global Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 3 Global Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 4 Global Organoids Market, By Application, 2020–2032 (Usd Million)
Table 5 Global Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 6 Global Organoids Market, By Region, 2020–2032 (Usd Million)
Table 7 North America: Organoids Market, By Country, 2020–2032 (Usd Million)
Table 8 North America Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 9 North America Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 10 North America Organoids Market, By Application, 2020–2032 (Usd Million)
Table 11 North America Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 12 Us Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 13 Us Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 14 Us Organoids Market, By Application, 2020–2032 (Usd Million)
Table 15 Us Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 16 Canada Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 17 Canada Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 18 Canada Organoids Market, By Application, 2020–2032 (Usd Million)
Table 19 Canada Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 20 Mexico Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 21 Mexico Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 22 Mexico Organoids Market, By Application, 2020–2032 (Usd Million)
Table 23 Mexico Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 24 Europe: Organoids Market, By Country, 2020–2032 (Usd Million)
Table 25 Europe Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 26 Europe Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 27 Europe Organoids Market, By Application, 2020–2032 (Usd Million)
Table 28 Europe Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 29 Germany Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 30 Germany Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 31 Germany Organoids Market, By Application, 2020–2032 (Usd Million)
Table 32 Germany Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 33 France Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 34 France Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 35 France Organoids Market, By Application, 2020–2032 (Usd Million)
Table 36 France Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 37 Uk Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 38 Uk Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 39 Uk Organoids Market, By Application, 2020–2032 (Usd Million)
Table 40 Uk Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 41 Spain Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 42 Spain Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 43 Spain Organoids Market, By Application, 2020–2032 (Usd Million)
Table 44 Spain Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 45 Italy Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 46 Italy Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 47 Italy Organoids Market, By Application, 2020–2032 (Usd Million)
Table 48 Italy Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 49 Rest Of Europe Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 50 Rest Of Europe Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 51 Rest Of Europe Organoids Market, By Application, 2020–2032 (Usd Million)
Table 52 Rest Of Europe Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 53 Asia Pacific: Organoids Market, By Country, 2020–2032 (Usd Million)
Table 54 Asia Pacific Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 55 Asia Pacific Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 56 Asia Pacific Organoids Market, By Application, 2020–2032 (Usd Million)
Table 57 Asia Pacific Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 58 China Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 59 China Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 60 China Organoids Market, By Application, 2020–2032 (Usd Million)
Table 61 China Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 62 India Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 63 India Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 64 India Organoids Market, By Application, 2020–2032 (Usd Million)
Table 65 India Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 66 Japan Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 67 Japan Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 68 Japan Organoids Market, By Application, 2020–2032 (Usd Million)
Table 69 Japan Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 70 South Korea Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 71 South Korea Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 72 South Korea Organoids Market, By Application, 2020–2032 (Usd Million)
Table 73 South Korea Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 74 Australia Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 75 Australia Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 76 Australia Organoids Market, By Application, 2020–2032 (Usd Million)
Table 77 Australia Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 78 Rest Of Asia Pacific Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 79 Rest Of Asia Pacific Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 80 Rest Of Asia Pacific Organoids Market, By Application, 2020–2032 (Usd Million)
Table 81 Rest Of Asia Pacific Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 82 Rest Of The World: Organoids Market, By Country, 2020–2032 (Usd Million)
Table 83 Rest Of The World Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 84 Rest Of The World Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 85 Rest Of The World Organoids Market, By Application, 2020–2032 (Usd Million)
Table 86 Rest Of The World Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 87 Middle East & Africa Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 88 Middle East & Africa Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 89 Middle East & Africa Organoids Market, By Application, 2020–2032 (Usd Million)
Table 90 Middle East & Africa Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 91 South America Organoids Market, By Product & Service, 2020–2032 (Usd Million)
Table 92 South America Organoids Market, By Type Of Organoids, 2020–2032 (Usd Million)
Table 93 South America Organoids Market, By Application, 2020–2032 (Usd Million)
Table 94 South America Organoids Market, By End-users, 2020–2032 (Usd Million)
Table 95 Major Players In The Global Organoids Market
Table 96 Product Launch/Development
Table 97 Contract & Agreement
Table 98 Hub Organoids: Products/Services Offered
Table 99 Neyroblastgx: Products Offered
Table 100 Stemcell Technologies: Products Offered
Table 101 Stemcell Technologies: Key Developments
Table 102 Bio-techne: Products Offered
Table 103 Bio-techne: Key Developments
Table 104 Thermo Fisher Scientific Inc: Products Offered
Table 105 3dnamics Inc.: Products Offered
Table 106 Molecular Devices, Llc: Products/Services Offered
Table 107 Molecular Devices, Llc: Key Developments
Table 108 Merck Kgga: Products Offered
Table 109 Corning Incorporated: Products Offered
Table 110 Cn Bio Innovations Ltd: Products Offered
List Of Figures
Figure 1 Global Organoids Market: Executive Summary
Figure 2 Global Organoids Market: Structure
Figure 3 Global Organoids Market: Market Growth Factor Analysis (2023-2032)
Figure 4 Value Chain Analysis Of The Global Organoids Market
Figure 5 Porter’s Five Forces Analysis: Global Organoids Market
Figure 6 Global Organoids Market, By Product & Service, 2023 & 2032(Usd Million)
Figure 7 Global Organoids Market Share (%), By Product & Service, 2023
Figure 8 Global Organoids Market, By Type Of Organoids, 2023 & 2032(Usd Million)
Figure 9 Global Organoids Market Share (%), By Type Of Organoids, 2023
Figure 10 Global Organoids Market, By Application, 2023 & 2032(Usd Million)
Figure 11 Global Organoids Market Share (%), By Application, 2023
Figure 12 Global Organoids Market, By End-users, 2023 & 2032(Usd Million)
Figure 13 Global Organoids Market Share (%), By End-users, 2022
Figure 14 Global Organoids Market, By Region, 2023 & 2032 (Usd Million)
Figure 15 Global Organoids Market Share, By Region, 2023 (% Share)
Figure 16 North America: Organoids Market Share, By Country, 2023 (% Share)
Figure 17 North America: Organoids Market, By Country, 2023 & 2032 (Usd Million)
Figure 18 Europe: Organoids Market Share, By Country, 2023 (% Share)
Figure 19 Europe: Organoids Market, By Country, 2023 & 2032 (Usd Million)
Figure 20 Asia Pacific: Organoids Market Share, By Country, 2023 (% Share)
Figure 21 Asia Pacific: Organoids Market, By Country, 2023 & 2032 (Usd Million)
Figure 22 Rest Of The World: Organoids Market Share, By Country, 2023 (% Share)
Figure 23 Rest Of The World: Organoids Market, By Country, 2023 & 2032 (Usd Million)
Figure 24 Benchmarking Of Major Competitors
Figure 25 Hub Organoids: Swot Analysis
Figure 26 Neyroblastgx: Swot Analysis
Figure 27 Stemcell Technologies: Swot Analysis
Figure 28 Bio-techne: Financial Overview Snapshot
Figure 29 Bio-techne: Swot Analysis
Figure 30 Thermo Fisher Scientific Inc.: Financial Overview Snapshot
Figure 31 Thermo Fisher Scientific Inc: Swot Analysis
Figure 32 3dnamics Inc.: Swot Analysis
Figure 33 Molecular Devices, Llc: Swot Analysis
Figure 34 Merck Kgaa: Financial Overview Snapshot
Figure 35 Merck Kgga: Swot Analysis
Figure 36 Corning Incorporated: Financial Overview Snapshot
Figure 37 Corning Incorporated: Swot Analysis
Figure 38 Cn Bio Innovations Ltd: Swot Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us